We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.91%
2 Healthcare 16.24%
3 Technology 15.4%
4 Industrials 13.98%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$174M 2.55%
4,113,916
+61,924
+2% +$2.59M
MSFT icon
2
Microsoft
MSFT
$3.81T
$156M 2.29%
1,824,605
-6,969
-0.4% -$572K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.19T
$139M 2.04%
2,653,940
+37,240
+1% +$1.9M
JPM icon
4
JPMorgan Chase
JPM
$951B
$121M 1.78%
1,132,902
+21,339
+2% +$2.16M
JNJ icon
5
Johnson & Johnson
JNJ
$646B
$113M 1.66%
810,344
+5,772
+0.7% +$804K
BDX icon
6
Becton Dickinson
BDX
$51.6B
$112M 1.64%
537,251
+70,478
+15% +$14.8M
MMM icon
7
3M
MMM
$89.9B
$109M 1.59%
551,620
-4,149
-0.7% -$798K
ACN icon
8
Accenture
ACN
$116B
$106M 1.55%
690,980
-3,392
-0.5% -$492K
COST icon
9
Costco
COST
$419B
$96.1M 1.41%
516,412
-2,475
-0.5% -$427K
ITW icon
10
Illinois Tool Works
ITW
$79.8B
$92.9M 1.36%
556,593
-4,767
-0.8% -$760K
CMCSA icon
11
Comcast
CMCSA
$96B
$90.8M 1.33%
2,268,372
+7,810
+0.3% +$294K
PNC icon
12
PNC Financial Services
PNC
$96.6B
$89.4M 1.31%
619,808
+5,528
+0.9% +$764K
V icon
13
Visa
V
$712B
$89.3M 1.31%
783,579
-1,093
-0.1% -$121K
ATR icon
14
AptarGroup
ATR
$8.46B
$85.1M 1.25%
986,274
+38,201
+4% +$3.33M
USB icon
15
US Bancorp
USB
$97.3B
$81.9M 1.2%
1,528,230
+2,420
+0.2% +$130K
ADP icon
16
Automatic Data Processing
ADP
$114B
$81.8M 1.2%
697,884
-4,849
-0.7% -$554K
ORCL icon
17
Oracle
ORCL
$435B
$78.6M 1.15%
1,661,875
+16,453
+1% +$807K
UNP icon
18
Union Pacific
UNP
$183B
$77.3M 1.13%
576,317
-1,735
-0.3% -$209K
NKE icon
19
Nike
NKE
$58.7B
$74.2M 1.09%
1,185,503
-26,266
-2% -$1.51M
UNH icon
20
UnitedHealth
UNH
$353B
$71.2M 1.04%
323,084
+850
+0.3% +$180K
HUBB icon
21
Hubbell
HUBB
$24.3B
$68.2M 1%
503,745
+4,056
+0.8% +$506K
CSCO icon
22
Cisco
CSCO
$433B
$65.7M 0.96%
1,716,207
+188,145
+12% +$6.72M
PEP icon
23
PepsiCo
PEP
$193B
$65M 0.95%
541,702
-3,876
-0.7% -$443K
ROST icon
24
Ross Stores
ROST
$73.3B
$63.9M 0.94%
795,672
-17,095
-2% -$1.2M
SYK icon
25
Stryker
SYK
$127B
$63.7M 0.93%
411,536
-16,071
-4% -$2.45M
1
2 3 4 5

Similar funds

MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.